More Indian Firms Dip Toes In Vaccines Segment: Just 'Opportunistic'?

The vaccines segment continues to draw the interest of participants beyond those firms with a traditional core presence, with new players largely building partnered capabilities around COVID-19 inoculations. Are these merely opportunistic forays or will the competitive landscape for vaccines stand altered more widely?.

Birds feeding
Growing Interest In Vaccines Segment • Source: Alamy

The vaccines space has traditionally been the preserve of a select group of companies but the pandemic has changed it all quite markedly, at least in India.

There’s been a stream of conventionally non-vaccine biopharma firms keen to tap into the segment, essentially via alliances for now

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Scrip